SIMPLINEXT
SIMPLINEXT
Industry:
Health Care
Founded:
2016-01-01
Address:
Neuchâtel, Neuchatel, Switzerland
Country:
Switzerland
Website Url:
http://www.simplinext.com
Total Employee:
1+
Status:
Active
Total Funding:
30 K CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Mobile Non Scaleable Content IPv6
Current Employees Featured
Founder
Investors List
Venture Kick
Venture Kick investment in Grant - SiMPLInext
Venture Kick
Venture Kick investment in Grant - SiMPLInext
Official Site Inspections
http://www.simplinext.com
- Host name: 217-160-0-127.elastic-ssl.ui-r.com
- IP address: 217.160.0.127
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "SiMPLInext"
SiMPLI next – Advancing in-vitro through innovation and …
SiMPLInext SA today announces its P-line products, for immediate release, comprising a complete set of complementary products from its SiMPLI & CoMPLI product families for industrial autonomous automatic TEER (Transepithelial Electrical Resistance) measurements of in vitro …See details»
SiMPLInext - Crunchbase Company Profile & Funding
SiMPLInext advancing in-vitro through innovation and ergonomics. P-line products: A set of products designed for autonomous automatic TEER measurements of in vitro reconstituted human biological barriers.See details»
SiMPLInext SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SiMPLInext SA of Biel/Bienne, BERNE. Get the latest business insights from Dun & Bradstreet.See details»
SiMPLInext SA - Swiss Biotech
SiMPLInext SA . Swiss Biotech Association ... Axxam is an innovative research and discovery organization providing services for the identification and validation of bioactive molecules across the life sciences industry and supporting pharmaceutical and biotech companies from target …See details»
SiMPLInext - Contacts, Employees, Board Members, Advisors
SiMPLInext advancing in-vitro through innovation and ergonomics.See details»
SiMPLInext SA - Venturelab
Aug 19, 2016 SiMPLInext SA. Incorporated 19.08.2016. Headquarters Biel/ Bienne. Support. The need for predictive models of human tissue engineered in vitro, as alternative to test on animals, has spurred the commercialization of …See details»
SiMPLInext - Funding, Financials, Valuation & Investors - Crunchbase
SiMPLInext advancing in-vitro through innovation and ergonomics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How much funding has this organization raised over time? Show . Announced Date . Transaction Name . …See details»
SiMPLInext SA Overview | SignalHire Company Profile
SiMPLInext SA acts in the field of advanced cell culture. Current conventional tissue models are unreliable to the point that they cannot be used as in vivo testing replacement. ... Organization Website: simplinext.com : SiMPLInext SA industries Biotech: Headquarters Location: Rue Fritz …See details»
Contact us - SiMPLI next
SiMPLINext SA Silvia Angeloni rue Fritz-Oppliger 18 2504 Biel/Bienne – SwitzerlandSee details»
SiMPLInext SA - VentureRadar
Find out more about SiMPLInext SA, Biotech, Biotechnology and Life Sciences. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) Funding Deals Hub; Similar Companies App; Manage Account; Logout; Login Free Sign-up , . ...See details»
SiMPLInext - Products, Competitors, Financials, Employees, …
SiMPLInext is a company focused on advancing in-vitro technologies within the biotechnology sector. Use the CB Insights Platform to explore SiMPLInext's full profile. SiMPLInext - Products, Competitors, Financials, Employees, Headquarters LocationsSee details»
SiMPLInext SA - startup.ch
SiMPLInext SA: The need for predictive models of human tissue engineered in vitro, as alternative to test on animals, has spurred the commercialization of disruptive approaches such as organoids and organ-on-a-chip. These solutions have a high adoption barrier and do not meet a …See details»
SiMPLInext Company Profile: Funding, Investors & Partnerships
SiMPLInext SA acts in the field of advanced cell culture. SiMPLInext provides a drop in replacement cell culture insert, which radically enhances the reliability, relevance, reproducibility, scope and quality of data acquired using in vitro models of biological barriers. Our inserts allow …See details»
Simplinext - Overview, Competitors and Decision Makers from …
Simplinextis headquartered in Switzerland, - specialized in Biotechnology - Find employees, decision makers, competitors and company information. DataLead allows to search for B2B contacts and companies by job title, location, keywords, industries, experience, education and …See details»
SiMPLInext - STI-Stiftung
SiMPLInext. Market acceptance of Consumers Goods and Chemicals and Pharma passes through mandatory tests on animals. However, physicians object that data obtained on different species are not valid for humans. The solution to this contradiction is the in vitro approach, …See details»
SiMPLInext - Tech Stack, Apps, Patents & Trademarks - Crunchbase
SiMPLInext advancing in-vitro through innovation and ergonomics. Experience the new Crunchbase, powered by AISee details»
SiMPLInext | Team Members | Digital Health Startup - HealthTech …
SiMPLInext provides a drop in replacement cell culture insert, which radically enhances the reliability, relevance, reproducibility, scope and quality of data acquired using in vitro models of biological barriers. Our inserts allow to culture better biological barriers, they allow to quality …See details»
Digital solution for the tissue engineering of the future by …
The vision of SiMPLInext SA is to simplify in vitro tissue engineering through intelligent laboratory devices and to enable sustainable toxicological testing with a high-quality standard.See details»
SiMPLInext – STI Foundation
SiMPLInext. Market acceptance of Consumers Goods and Chemicals and Pharma passes through mandatory tests on animals. However, physicians object that data obtained on different species are not valid for humans. The solution to this contradiction is the in vitro approach, …See details»
Press release - 04 Dec 2018 SiMPLInext
Partners: SiMPLInext is currently in discussion with partners for participation in development, production and combined usage of its products. SiMPLInext cooperates with DATSA Belgium, that operates the joint IDA-lab for the CoMPLI development. Geographic area: products are …See details»